Brief: Dicot Pharma Submits Patent Application For LIB-01
21/11/2025 09:46
Nov 21 (Reuters) - Dicot Pharma AB DICOT.ST: SUBMITS PATENT APPLICATION FOR LIB-01 PATENT APPLICATION BASED ON LONG-TERM EFFECT FROM PHASE 2A STUDY PATENT PROTECTION CURRENTLY LASTS UNTIL 2042 PHASE 2B STUDY PLANNED TO BEGIN IN 2026 Source text: ID:nMFN1qHbyd Further company coverage: DICOT.ST (Gdansk Newsroom) ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))
Recent news on Dicot Pharma AB
See all newsBrief: Dicot Pharma Recruits Cecilia Driving As CFO
Brief: Dicot Pharma Gets FDA Clearance To Start First Part Of Phase 2B Study With Lib-01 In U.S.
Brief: Dicot Pharma Announces Outcome In Oversubscribed Rights Issue
Brief: Dicot Pharma Announces Prelim Rights Issue Outcome
Brief: Dicot Pharma Submits IND Application To FDA